Advertisement
Home Tags Meningitis

Tag: Meningitis

Coverage with the human papillomavirus vaccine increased among boys from 2017 to 2018

Coverage With HPV Vaccine Continuing to Increase in Boys

0
Teens whose parents received a provider recommendation had higher coverage with HPV vaccine
Metagenomic next-generation sequencing of cerebrospinal fluid obtained from patients with meningitis or encephalitis can improve diagnosis of neurologic infections

Next-Gen Sequencing of CSF Improves Diagnosis of CNS Infections

0
Eight of 13 diagnoses made solely by metagenomic NGS had likely clinical effect, seven guided treatment
Achieving high serogroup B meningococcal vaccination coverage is recommended following university-based outbreaks of meningococcal disease caused by serogroup B

High Rates of MenB Vaccination Advised in University Outbreaks

0
Estimated first-dose vaccination coverage varied from 14 to 98 percent in 10 university outbreaks
College students have an increased risk for sporadic and outbreak-associated serogroup B meningococcal disease

College Students at Increased Risk for SgB Meningococcal Dz

0
Students, parents, health care providers should be aware of the availability of MenB vaccines
Universal vaccination against Neisseria meningitidis serogroup B at college entry does not appear to be cost-effective

Universal Vaccination for MenB at College Entry Not Cost-Effective

0
Incremental cost per quality-adjusted life-year gained $13.8 million under societal perspective
U.S. pediatricians and family physicians have considerable knowledge gaps regarding serogroup B meningococcal vaccination

Physicians Lack Knowledge About Serogroup MenB Vaccination

0
Primary care docs who are somewhat or not aware of MenB vaccine are less likely to discuss vaccination
Viruses are the most commonly identified cause of meningitis among U.K. adults

Viruses ID’d As Most Common Cause of Meningitis in U.K. Adults

0
Estimated annual incidence of viral meningitis is 2.73 per 100,000 U.K. adults
A bivalent meningococcal B vaccine targeting factor H-binding protein elicits bactericidal responses against diverse meningococcal B strains after two and three doses in adolescents and young adults

Bivalent Meningococcal B Vaccine Safe, Immunogenic

0
Elicits bactericidal responses against diverse meningococcal B strains in teens, young adults
Meningococcal disease can occur in eculizumab recipients who have been vaccinated

Meningitis After Vaccination in Eculizumab Recipients

0
Sixteen cases of meningococcal disease reported in eculizumab recipients during 2008 to 2016
For adolescents

Effectiveness of One-Dose MenACWY-D Drops Over Time

0
Effectiveness 79 percent at less than one year, drops to 61 percent at three to less than eight years